Schlafförderung bei onkologischen Patienten

Schlafstörungen sind eines der belastendsten Symptome bei onkologischen Patienten. Die modulare Intervention der pflegewissenschaftlichen Studie am Uniklinikum Tübingen basiert auf Assessment, strukturierter Beratung mittels Infobroschüre, Schlaftagebuch und telefonischer Nachbetreuung zur Förderung der Patientenautonomie. Vor allem tagesklinische sowie Patienten mit Chemo- und Strahlentherapie profitierten von dem Angebot.

• Literatur

• 1 Aaronson NK. et al. The European Organization for Research and Treatment of Cancer QLQ-30: a quality-of-life instrument for use in international clinical trials in oncology. J Nat Cancer Inst 1993; 85 (05) 365-376.
• 2 Ancoli-Israel S, Cole R, Alessi C. et al. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003; 26 (03) 342-392.
• 3 Bamberger GC. Lösungsorientierte Beratung. Weinheim, Basel: Beltz; 4. Auflage. 2010.
• 4 Benor DE, Delbar V, Krulik T. Measuring impact of nursing intervention on cancer patients’ ability to control symptoms. Cancer Nursing 1998; 21 (05) 320-334.
• 5 Berger AM, Kuhn BR, Farr LA. et al. Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue. Psychooncology 2009; 18 (06) 634-646.
• 6 Buysse DJ, Barzansky B, Dinges D. et al. Sleep, fatigue, and medical training: setting an agenda for optimal learning and patient care. Sleep 2003; 28 (02) 218-225.
• 7 Buysse DJ. et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatric Research 1989; 28 (02) 193-213.
• 8 Clark J. et al. Sleep-wake disturbances in people with cancer part II: evaluating the evidence for clinical decision making. Oncol Nursing Forum 2004; 31 (04) 747-771.
• 9 Davidson JR. et al. Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psychooncology 2001; 10 (05) 389-397.
• 10 Demiralp M, Oflaz F, Komurcu S. Effects of relaxation training on sleep quality and fatigue in patients with breast cancer undergoing adjuvant chemotherapy. J Clin Nursing 2010; 19 (7–8): 1073-1083.
• 11 Dirksen SR, Epstein DR. Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Advanced Nursing 2008; 61 (06) 664-675.
• 12 Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health psychology: American Psychological Association 2006; 25 (01) 3-14.
• 13 Krebsforschungszentrum. Krebsstatistiken: Wie häufig ist Krebs in Deutschland?. 12.07.2012 unter http://www.kreb sinformation.de/grundlagen/krebsstatistiken.php#inhalt2.
• 14 Mayer G, Fietze I, Fischer J. et al. (Hrsg.) S3-Leitlinie Nichterholsamer Schlaf / Schlafstörungen der Deutschen Gesellschaft für Schlafforschung und Schlafförderung (DGSM). Somnologie 2009; 13: 4-160.
• 15 NIH. State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults. Sleep 2005; 28 (09) 1049-1057.
• 16 Northouse LL. et al. The quality of life of African American women with breast cancer. Research in Nursing & Health 1999; 22 (06) 449-460.
• 17 Page MS, Berger AM, Johnson LB. Putting evidence into practice: evidence-based interventions for sleep-wake disturbances. Clin J Oncol Nursing 2006; 10 (06) 753-767.
• 18 Price MA. et al. Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor. Eur J Cancer 2009; 45 (18) 3262-3270.
• 19 Quesnel C. et al. Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J Consult Clin Psychology 2003; 71 (01) 189-200.
• 20 Renz P, Mohr J, Klump C. Entwicklung eines evidenzbasierten Beratungsprogrammes zur Schlafförderung bei onkologischen Patienten. Z f Pflegewissensch. 2013 (in press)
• 21 Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncology 2005; 23 (25) 6083-6096.
• 22 Sitzia J, Huggins L. Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer. Cancer Practice 1998; 6 (01) 13-21.
• 23 Smets EMA. et al. The Multidimensional Fatigue Inventory (MFI). Psychometric qualities of an instrument to assess Fatigue. J Psychosomatic Res 1995; 39 (05) 315-325.
• 24 Theobald DE. Cancer pain, fatigue, distress, and insomnia in cancer patients. Clin Cornerstone 2004; 6 (Suppl 1D): 15-21.